In hepatocellular carcinoma, PLCE1 was significantly increased from 0.62 ± 0.15 in normal (n = 220) to 0.78 ± 0.34 in hepatocellular carcinoma (n = 225) (Figure 7F), and PRKCA was increased from 4.90 ± 1.46 in normal to 7.13 ± 4.22 in hepatocellular carcinoma (Figure 7F). This evidence concerns the gene PLCE1 and hepatocellular carcinoma.